Financials

News Ideas Discussions Technicals Seasonals

FLUI fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Fluicell AB engages in the provision of fluid platforms for multi-functional pipettes for cell-based pharmacology research. Its products include Biopen Prime and Flex, Dynaflow Resolve, and Biopixlas. The company was founded by Aldo Jesorka, Alar Ainla, and Gavin David Michael Jeffries on January 2, 2012 and is headquartered in Molndal, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

FLUI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company